These results indicated that hucMSCs could improve the aging of renal tissues in diabetes rats through AMPK/mTOR pathway, which partly verified the in vitro mechanisms of hucMSCs in DN treatment. This evidence concerns the gene MTOR and liver dysplastic nodule.